Mannkind (MNKD) Net Margin Growth (5y) (2017 - 2026)
Mannkind (MNKD) Net Margin Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,565.00 |
| Dec 31, 2025 | 12,896.00 |
| Sep 30, 2025 | 8,303.00 |
| Jun 30, 2025 | 512,684.00 |
| Mar 31, 2025 | 7,421.00 |
| Dec 31, 2024 | -22,032.00 |
| Sep 30, 2024 | 149,791.00 |
| Jun 30, 2024 | 619,072.00 |
| Mar 31, 2024 | 10,134.00 |
| Dec 31, 2023 | 4,746.00 |
| Sep 30, 2023 | 54,777.00 |
| Jun 30, 2023 | 57,162.00 |
| Mar 31, 2023 | 85,280.00 |
| Dec 31, 2022 | 67,394.00 |
| Sep 30, 2022 | 156,573.00 |
| Jun 30, 2022 | 148,019.00 |
| Mar 31, 2022 | 32,571.00 |
| Dec 31, 2021 | -65,935.00 |
| Sep 30, 2021 | -9,786.00 |
| Sep 30, 2017 | 12.08 Mn |